Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report) and ...

Citi initiated coverage of Cytokinetics (CYTK) with a Buy rating and $86 price target. The shares seem attractive at current levels, given the ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of ...

Shares of Cytokinetics CYTK gained 2.2% on Wednesday after the company began enrolling patients in its mid-stage study of CK-4021586 (CK-586), a cardiac myosin inhibitor, for treating heart ...

“The landscape in health care is awful, and it’s only getting worse,” Main Line CEO Jack Lynch said in an interview. Lynch cited as factors: inadequate payment increases from Medicare and Medicaid, ...

$10,000 of CYTOKINETICS INC. lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "General healthcare representation.

Facing high out-of-pocket costs and deductibles, many are forced to skip needed care or take on medical debt even when they have healthcare coverage. Delaying care has dire health consequences ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

a district that backed Vice President Kamala Harris in the 2024 cycle — and your party asks you to support an agenda that takes health care benefits from poor families to finance tax breaks for ...

Walmart announced on Monday that it had unveiled a new logo, part of "a comprehensive brand refresh." The U.S.-based retailer boasted in a news release that the new look — its first change ...